Certain Warrants of Hillstream BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 24-OCT-2023. These Warrants will be under lockup for 180 days starting from 27-APR-2023 to 24-OCT-2023.

Details:
Executive officers and directors have agreed, for a period of 180 days from the date of this prospectus supplement not to, directly or indirectly, offer to sell, sell, pledge or otherwise transfer or dispose of any of shares of (or enter into any transaction or device that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) common stock, enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for shares of common stock or any other of securities or publicly disclose the intention to do any of the foregoing, subject to customary exceptions, without the prior written consent of the representative.